Siegfried Holding AG, founded in 1873, is a Health Care company based in Zofingen, Switzerland. Its directors and officers file their transactions with SIX SER. No insider at Siegfried Holding AG has published a filing in the past twelve months. The most recent one dates from 31 October 2024.
In the same sector, recent insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. also feature in our signals. This summary is built from SIX SER disclosures alone and does not predict where the share price will go.
Analysts rate Siegfried Holding AG Buy (bullish), based on 12 analysts. Average price target: CHF 98.17.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
13 of 13 declarations
Siegfried Holding AG is a Swiss company operating in the health and pharmaceutical sector. It focuses on the development and production of pharmaceuticals and pharmaceutical chemicals.
Headquarters: Zofingen, Switzerland · Founded: 1873 · Wikipedia article
Source: Wikidata (CC0).